Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-124325
Filing Date
2026-03-25
Accepted
2026-03-25 17:07:11
Documents
1
Period of Report
2026-03-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3993
  Complete submission text file 0001193125-26-124325.txt   5442
Mailing Address C/O XENON PHARMACEUTICALS INC. 3650 GILMORE WAY BURNABY British Columbia, Canada V5G 4W8
Business Address
Cline Darren S (Reporting) CIK: 0001633639 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 26793423

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)